Primary Care POC Diagnostics Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

The Primary Care POC Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Primary Care POC Diagnostics Market Size and Its Estimated Growth Rate?
The primary care point-of-care (POC) diagnostics market has seen strong growth in recent years. It will rise from $16.46 billion in 2024 to $17.78 billion in 2025, with a CAGR of 8.0%. This growth is driven by the increasing prevalence of chronic diseases, a shift toward personalized medicine, rising healthcare expenditure, supportive regulatory frameworks, and a growing emphasis on early disease detection and prevention.

The primary care POC diagnostics market is expected to grow to $23.86 billion by 2029 at a CAGR of 7.6%. This growth is driven by the rise of infectious diseases, expanding applications in non-communicable diseases, increased adoption in home healthcare, precision medicine, healthcare infrastructure investments, and the growing need for early disease detection. Trends include the integration of AI and machine learning algorithms, advancements in molecular diagnostics, miniaturization of POC devices, smart device integration, and the use of multiplexing and panel testing.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15642

How Are Emerging Segments Shaping the Primary Care POC Diagnostics Market Landscape?
The primary care POC diagnostics market covered in this report is segmented -

1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products
2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses

Subsegments:
1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions
2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices
3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests
4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors
5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices
6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits
7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices
8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices
9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests
10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp

Which Growth Factors Are Influencing Primary Care POC Diagnostics Market Expansion?
The rise in infectious diseases is likely to drive the growth of the primary care point-of-care (POC) diagnostics market. Infectious diseases, caused by pathogens such as bacteria and viruses, are increasing due to factors like inadequate vaccination and antimicrobial resistance. Primary care POC diagnostics play a vital role in early detection and disease management. In 2023, the UK Health Security Agency reported a 22% rise in HIV diagnoses in England, while the World Health Organization reported 10.6 million cases of tuberculosis globally in 2022, propelling the primary care POC diagnostics market.

Who Are the Dominant Players Across Different Primary Care POC Diagnostics Market Segments?
Major companies operating in the primary care POC diagnostics market are Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Becton, Dickinson And Company, bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics, Nipro Corporation, OraSure Technologies, Meridian Bioscience Inc., DiaSorin SpA, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, Fujirebio Diagnostics Inc., Immunodiagnostic Systems Holdings PLC, Quotient Limited, AccuBioTech Co. Ltd., bioMedomics Inc.

What Are the Major Trends Shaping the Primary Care POC Diagnostics Market?
Companies in the primary care point-of-care diagnostics market are advancing portable RT-PCR solutions to enhance their revenue streams. These mobile devices conduct RT-PCR tests outside traditional laboratory settings. For example, in October 2022, Genes2Me Pvt. Ltd., an India-based diagnostic manufacturer, launched the Rapi-Q Point of Care RT-PCR solution, which offers rapid and accurate results in less than 45 minutes, particularly for diseases like HPV and tuberculosis.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report

Which Geographic Regions Are Expected to Dominate the Primary Care POC Diagnostics Market in the Coming Years?
North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Primary Care POC Diagnostics Market?
2. What is the CAGR expected in the Primary Care POC Diagnostics Market?
3. What Are the Key Innovations Transforming the Primary Care POC Diagnostics Industry?
4. Which Region Is Leading the Primary Care POC Diagnostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.